1. Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
   Abderrahim El Guerrab et al, 2020, Scientific Reports CrossRef
2. SHOC2 mediates the drug-resistance of triple-negative breast cancer cells to everolimus
   Wenwen Geng et al, 2023, Cancer Biology & Therapy CrossRef
3. Colon cancer – new strategies of treatment
   Anna Międzybrodzka et al, 2019, Annales Academiae Medicae Silesiensis CrossRef